| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $1.24 | 990 | 1,228 | 22,910 | Mar 05, 2024, 05:02 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 02, 2024 | Option Exercise | $1.24 | 427 | 529 | 23,983 | Mar 05, 2024, 05:02 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Sep 06, 2023 | Buy | $7.90 | 9,490 | 74,971 | 15,461 | Sep 07, 2023, 04:16 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Sep 01, 2023 | Option Exercise | $7.90 | 285 | 2,252 | 5,971 | Sep 05, 2023, 05:08 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 02, 2023 | Sale | $12.29 | 1,000 | 12,289 | 4,650 | Mar 03, 2023, 08:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 03, 2023 | Sale | $12.63 | 894 | 11,290 | 5,256 | Mar 03, 2023, 08:09 PM |
Menu